Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-08-05
Buyer: NHS Lothian
Country: UK
Contract type: Services
Procedure: Negotiated without a prior call for competition
CPV classification: 48000000
Estimated value: 312529.36 GBP

Technical requirements: This is a voluntary ex ante transparency (VEAT) notice. The provision of ongoing support for software in which the contracting authority holds a perpetual licence and which is used to support the administration of the chemotherapy electronic prescribing system for Health Boards within NHS Scotland which in turn delivers critical clinical services to citizens.
The provision of ongoing support for software in which the contracting authority and also Borders, Fife and Dumfries and Galloway Health Boards holds a fully paid up perpetual licence and which is used to support the administration of the chemotherapy electronic prescribing system for Health Boards within NHS Scotland which in turn delivers critical clinical services to citizens. The proposed contract will provide continuity of service based upon the existing solution in which there has been significant prior investment, development of expertise within the user community and on which current operational processes within the contracting authority and other Health Boards within NHS Scotland rely. As a result there is no financially or administratively reasonable or viable alternative to the current system to meet the needs of the service during the minimum period of the proposed contract. The proposed contract will be for a period of three years with the option of an extension for a further one year period.
The contracting authority and also Borders, Fife and Dumfries and Galloway Health Boards holds a fully paid up perpetual licence to use the software from the incumbent supplier. The incumbent supplier owns the intellectual property rights in the software and is therefore the only economic operator who can supply the required support services for continued use of the software. The proposed contract will provide continuity of service based upon the existing solution in which there has been significant prior investment, development of expertise within the user community and on which current operational processes within the contracting authority and other Health Boards within NHS Scotland rely. As a result there is no financially or administratively reasonable or viable alternative to the current system to meet the needs of the service during the minimum period of the proposed contract. The proposed contract will be for a period of three years with the option of an extension for a further one year period. The contracting authority (in conjunction with other Health Boards within NHS Scotland) will, during the life of the proposed contract, review their requirements with regard to the chemotherapy electronic prescribing system services with a view to holding a future re-procurement exercise.
NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=592720.


Winner: CIS Oncology
Award value: 312529.36